Preclinical studies using mouse models have demonstrated that the elevation of expression of PDGF-C in aged or fibrotic lungs in each case contributed to enhanced awakening and metastatic relapse of estrogen receptor-positive breast cancer cells [237]. This evidence concerns the gene ESR1 and breast carcinoma.